Sarah Missel joined Immatics in 2011, where she started as Scientist in Immunology and subsequently held several positions leading cross-functional teams in various internal and collaboration projects. Her work as Senior Director Translational Development is focused on R&D strategy and communications, as well as translation of preclinical projects into early phase clinical trials with a current focus on T cell engaging bispecifics (TCER™) and personalized immunotherapies.
Sarah studied Pharmacy at the University of Würzburg and gathered some experience in clinical research at GSK. Her academic research at the Institute of Virology of TU/Helmholtz Centre Munich was focused on therapeutic HIV vaccines and immune monitoring in clinical trials.
Sarah Missel holds a State Exam in Pharmacy and a PhD in Pharmacology/Immunology/Virology from LMU and Helmholtz Centre Munich